Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,142
  • Shares Outstanding, K 16,480
  • Annual Sales, $ 29,660 K
  • Annual Income, $ -6,460 K
  • 60-Month Beta 1.08
  • Price/Sales 3.75
  • Price/Cash Flow N/A
  • Price/Book 1.90
Trade BWAY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.07
  • Low Estimate -0.09
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.03 +26.84%
on 05/12/22
8.14 -21.62%
on 04/26/22
-1.36 (-17.57%)
since 04/22/22
3-Month
5.03 +26.84%
on 05/12/22
9.18 -30.50%
on 04/01/22
-1.45 (-18.52%)
since 02/23/22
52-Week
5.03 +26.84%
on 05/12/22
11.77 -45.78%
on 05/28/21
-3.29 (-34.02%)
since 05/21/21

Most Recent Stories

More News
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, May 11,...

BWAY : 6.38 (-5.48%)
BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month

BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health America...

BWAY : 6.38 (-5.48%)
BrainsWay to Report First Quarter Financial Results on May 11, 2022

BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.38 (-5.48%)
Megastar HR Launches Stellar HR Services with Grand Opening

New Utah-based HR firm aims to reverse declining nationwide employee engagement rates SANDY, UT / ACCESSWIRE / April 25, 2022 / According to a 2021 Gallup survey, only 36% of employees are engaged at work....

BWAY : 6.38 (-5.48%)
DYNT : 0.6517 (-0.20%)
BrainsWay Appoints Dr. Joachim Seidel as Vice President of Corporate Development and Strategy

Dr. Seidel has more than 20 years of experience in the medical device industry...

BWAY : 6.38 (-5.48%)
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights

Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding FDA Labeling for Deep TMS™ and Increasing Payor...

BWAY : 6.38 (-5.48%)
BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference

BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.38 (-5.48%)
BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BURLINGTON, Mass. and JERUSALEM, Feb. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.38 (-5.48%)
BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD

Palmetto GBA Covers Medicare Patients in Seven States...

BWAY : 6.38 (-5.48%)
BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board

World-Renowned Specialist in Addiction and Anxiety Treatment Joins Premier Group of Researchers and Clinicians Advising Company...

BWAY : 6.38 (-5.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 6.92
2nd Resistance Point 6.81
1st Resistance Point 6.59
Last Price 6.38
1st Support Level 6.27
2nd Support Level 6.17
3rd Support Level 5.95

See More

52-Week High 11.77
Fibonacci 61.8% 9.19
Fibonacci 50% 8.40
Fibonacci 38.2% 7.60
Last Price 6.38
52-Week Low 5.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar